GlaxoSmithKline Settles Again Over Zantac Cancer Claims

Header image

GSK Settles Out Of Court For The Second Time This Year Over Zantac Cancer Claims, Preempting Trials Amid Allegations Linking The Drug To Carcinogens.

GlaxoSmithKline (GSK), the pharmaceutical giant responsible for Zantac, has opted for an out-of-court settlement for the second time this year.

This move comes amidst ongoing allegations that Zantac, once a popular remedy for heartburn, may have been more harmful than helpful due to its potential to develop a carcinogenic byproduct.

On February 29, GSK released a statement confirming a confidential settlement in a lawsuit that claimed Zantac was linked to cancer due to its active ingredient, ranitidine. This settlement comes ahead of a trial that was scheduled for April 2.

Earlier this year, GSK reached a similar settlement in the case filed by David Browne, bypassing the scheduled trial date of February 20. These quiet maneuvers to settle are becoming a recognizable part of GSK's legal playbook.

Pulling Zantac off shelves

The decision to recall Zantac and its generic versions in April 2020 by the FDA was a direct reaction to the discovery of N-Nitrosodimethylamine (NDMA) at unsafe levels, raising significant health concerns.

NDMA is known to potentially cause cancer, and its connection with ranitidine has become the focus of the lawsuits against Zantac.

Grasping the magnitude of litigation

The legal troubles for GSK, alongside other pharmaceutical corporations like Boehringer Ingelheim, Pfizer, and Sanofi, are monumental, with around 80,000 lawsuits filed in various state courts. Most of these cases are concentrated in Delaware.

These lawsuits have been brought forward by individuals who used Zantac or its generic equivalents and later experienced serious health issues. The plaintiffs have reported a range of cancers, including bladder, liver, pancreatic, and stomach cancers, which they attribute to their use of the medication.

Despite settling these recent cases, GSK and its co-defendants have not admitted any wrongdoing or liability. They continue to contest the claims based on scientific defenses and maintain their stance in the face of numerous ongoing lawsuits.

If you or a loved one has been affected by Zantac, experiencing health complications or facing the loss of someone due to potential side effects of the medication,  you may have a right to compensation.

Consulting with a legal expert who is well-versed in the Zantac litigation could be your next step to holding the drug maker accountable and potentially financial relief for those harmed. Take a moment to fill out our form for a complimentary case evaluation— because knowing your rights is the first step towards getting justice.



Illustration of a mobile device getting an email notification
Our Mission at Injury Claims

Injury Claims keeps you informed about lawsuits large and small that could affect your daily life. We simplify the complexities of class actions lawsuits, open class action settlements, mass torts, and individual cases to ensure you understand how these legal matters could impact your rights and interests.

Legal Updates That Matter to You

If you think a recent legal case might affect you, action is required. Select a class action lawsuit or class action settlement, share your details, and connect with a qualified attorney who will explain your legal options and assist in pursuing any compensation due. Take the first step now to secure your rights.